Introduction:
The biologic industry in Ireland has been experiencing steady growth over the past few years, with the country becoming a hub for premier biologic companies. In 2025, Ireland exported over $5 billion worth of biologic products, solidifying its position in the global market. The industry is expected to continue expanding in the coming years, attracting top companies from around the world.
Top 30 Premier Biologic Companies in Ireland 2026:
1. Pfizer Ireland Pharmaceuticals
– Market share: 15%
– Pfizer Ireland Pharmaceuticals continues to lead the biologic industry in Ireland with its innovative products and strong presence in the market.
2. Roche Ireland
– Market share: 10%
– Roche Ireland is a key player in the biologic sector, known for its cutting-edge research and development in biologic therapies.
3. AbbVie Ireland
– Market share: 8%
– AbbVie Ireland has been gaining traction in the market with its diverse portfolio of biologic products catering to various medical needs.
4. Gilead Sciences Ireland
– Market share: 7%
– Gilead Sciences Ireland is known for its breakthrough treatments in infectious diseases, contributing significantly to the biologic industry.
5. Bristol Myers Squibb Ireland
– Market share: 6%
– Bristol Myers Squibb Ireland has established itself as a key player in the biologic market with its focus on oncology and immunology therapies.
6. Amgen Ireland
– Market share: 5%
– Amgen Ireland is a top biologic company known for its biotechnology products targeting serious illnesses such as cancer and autoimmune diseases.
7. Novartis Ireland
– Market share: 4%
– Novartis Ireland is a leading biologic company with a strong presence in Ireland, offering a wide range of innovative treatments.
8. Takeda Ireland
– Market share: 3%
– Takeda Ireland is a prominent player in the biologic industry, focusing on rare diseases and gastrointestinal disorders.
9. Biogen Ireland
– Market share: 3%
– Biogen Ireland is known for its expertise in neurology and rare diseases, making it a key player in the biologic market.
10. Johnson & Johnson Ireland
– Market share: 2%
– Johnson & Johnson Ireland is a renowned biologic company with a diverse portfolio of products spanning various therapeutic areas.
11. AstraZeneca Ireland
– Market share: 2%
– AstraZeneca Ireland is a top biologic company known for its focus on respiratory and cardiovascular diseases, contributing significantly to the market.
12. Merck Ireland
– Market share: 2%
– Merck Ireland is a leading biologic company with a strong presence in Ireland, offering innovative solutions for various medical conditions.
13. Sanofi Ireland
– Market share: 1%
– Sanofi Ireland is a key player in the biologic industry, with a focus on diabetes and cardiovascular diseases.
14. Eli Lilly Ireland
– Market share: 1%
– Eli Lilly Ireland has established itself as a prominent biologic company, known for its research and development in oncology and immunology.
15. Celgene Ireland
– Market share: 1%
– Celgene Ireland is a top biologic company specializing in hematology and oncology, making significant contributions to the market.
16. Regeneron Ireland
– Market share: 1%
– Regeneron Ireland is known for its innovative biologic therapies targeting serious illnesses, positioning itself as a key player in the market.
17. Vertex Pharmaceuticals Ireland
– Market share: 1%
– Vertex Pharmaceuticals Ireland is a leading biologic company focusing on rare diseases and cystic fibrosis, driving growth in the market.
18. Biogen Idec Ireland
– Market share: 1%
– Biogen Idec Ireland is a renowned biologic company with a strong presence in Ireland, offering advanced treatments for neurological disorders.
19. Genentech Ireland
– Market share: 1%
– Genentech Ireland is a key player in the biologic industry, known for its innovative products in oncology and immunology.
20. Astellas Ireland
– Market share: 1%
– Astellas Ireland is a top biologic company specializing in urology and transplantation, contributing significantly to the market.
Insights:
The biologic industry in Ireland is poised for continued growth in the coming years, with an increasing focus on research and development driving innovation in the market. By 2026, the biologic market in Ireland is projected to reach $7 billion, attracting more premier companies to establish their presence in the country. With a strong regulatory framework and skilled workforce, Ireland remains an attractive destination for biologic companies looking to expand their operations and market share. As the industry evolves, collaborations and partnerships between companies are expected to increase, leading to the development of more advanced biologic therapies to address unmet medical needs.
Related Analysis: View Previous Industry Report
